GOODRX

Lobbying Spend

—

Filings

Firms Hired

Active Period

2018–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2020	—	1	1
2019	—	4	1
2018	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
S-3 GROUP	—	7
FAEGRE BAKER DANIELS CONSULTING	—	8

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	12
SENATE	12
Health & Human Services, Dept of (HHS)	6
Food & Drug Administration (FDA)	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	14
Pharmacy	Pharmacy	7

GOODRX — Lobbying Disclosure | Poliscope